34 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• Acorda Therapeutics, Inc. ACOR shares moved upwards by 13.8% to $2.23 during Friday's pre-market session. According to the most recent rating by JP Morgan, on October 24, the current rating is at Underweight.
• Ritter Pharmaceuticals, Inc. RTTR stock increased by 11.1% to $0.23.
• Chembio Diagnostics, Inc. CEMI stock increased by 10.1% to $5.02.
• BOQI International, Inc. BIMI stock moved upwards by 8.8% to $3.73.
• Aethlon Medical, Inc. AEMD shares surged 3.2% to $1.29.
• Onconova Therapeutics, Inc. ONTX shares rose 3.1% to $0.43.
• Titan Pharmaceuticals, Inc. TTNP shares surged 2.3% to $0.22. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
• Endo International, Inc. ENDP stock rose 2.2% to $4.60.
• Guardion Health Sciences, Inc. GHSI stock increased by 2.0% to $0.26.

Losers

• Novan, Inc. NOVN stock declined 74.0% to $0.81 during Friday's pre-market session.
• Mereo BioPharma Group, Inc. MREO shares fell 12.8% to $2.80.
• Pulmatrix, Inc. PULM stock fell 10.5% to $1.45.
• Viveve Medical, Inc. VIVE shares fell 9.1% to $1.00. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
• Jaguar Health, Inc. JAGX shares declined 8.3% to $0.72. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $3.00.
• Cassava Sciences, Inc. SAVA shares fell 7.8% to $6.64.
• Diffusion Pharmaceuticals, Inc. DFFN stock fell 6.4% to $0.43. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
• Neovasc, Inc. NVCN stock declined 5.9% to $3.65. The most recent rating by H.C. Wainwright, on October 24, is at Buy, with a price target of $9.00.
• Agile Therapeutics, Inc. AGRX stock fell 3.7% to $2.86.
• Rite Aid, Inc. RAD shares declined 3.5% to $14.00.
• MorphoSys, Inc. MOR stock plummeted 3.4% to $34.78. According to the most recent rating by Guggenheim, on November 20, the current rating is at Buy.
• Genfit, Inc. GNFT shares declined 2.9% to $20.07.
• Genmab, Inc. GMAB stock declined 2.7% to $21.69. The most recent rating by HC Wainwright & Co., on October 16, is at Buy, with a price target of $25.00.
• SmileDirectClub, Inc. SDC stock fell 2.4% to $8.12. The most recent rating by Goldman Sachs, on December 18, is at Neutral, with a price target of $10.00.
• Mednax, Inc. MD shares plummeted 2.4% to $26.84. The most recent rating by Citigroup, on January 03, is at Neutral, with a price target of $29.00.
• Galapagos, Inc. GLPG shares fell 2.2% to $207.50. According to the most recent rating by UBS, on December 20, the current rating is at Neutral.
• Teva Pharmaceutical Indus, Inc. TEVA stock fell 2.1% to $9.36. According to the most recent rating by JP Morgan, on November 12, the current rating is at Neutral.
• Amarin Corp, Inc. AMRN stock declined 2.0% to $21.10. The most recent rating by Oppenheimer, on December 16, is at Underperform, with a price target of $8.00.
• Grifols, Inc. GRFS stock declined 1.5% to $23.25. According to the most recent rating by Santander, on October 28, the current rating is at Buy.
• Bristol-Myers Squibb, Inc. BMY stock fell 1.5% to $62.38. The most recent rating by Argus Research, on December 13, is at Buy, with a price target of $80.00.
• GlaxoSmithKline, Inc. GSK stock decreased by 1.4% to $46.25. According to the most recent rating by UBS, on November 21, the current rating is at Buy.
• Biocept, Inc. BIOC shares declined 1.4% to $0.34.
• Canopy Growth, Inc. CGC shares fell 1.4% to $19.85. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
• AstraZeneca, Inc. AZN stock declined 1.4% to $49.71. The most recent rating by Cowen & Co., on December 02, is at Outperform, with a price target of $55.00.
• Qiagen, Inc. QGEN shares plummeted 1.3% to $33.49. The most recent rating by Bank of America, on December 26, is at Underperform, with a price target of $28.00.